161 related articles for article (PubMed ID: 2369419)
1. Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate.
Kujala GA; Shamma'a JM; Chang WL; Brick JE
Arthritis Rheum; 1990 Jul; 33(7):1037-41. PubMed ID: 2369419
[TBL] [Abstract][Full Text] [Related]
2. Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis.
Clegg DO; Furst DE; Tolman KG; Pogue R
J Rheumatol; 1989 Aug; 16(8):1123-6. PubMed ID: 2585411
[TBL] [Abstract][Full Text] [Related]
3. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
Phillips CA; Cera PJ; Mangan TF; Newman ED
J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
[TBL] [Abstract][Full Text] [Related]
4. The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
Bjorkman DJ; Boschert M; Tolman KG; Clegg DO; Ward JR
Arthritis Rheum; 1993 Dec; 36(12):1697-701. PubMed ID: 8250989
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
Aponte J; Petrelli M
Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364
[TBL] [Abstract][Full Text] [Related]
6. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
7. Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis.
Keim D; Ragsdale C; Heidelberger K; Sullivan D
J Rheumatol; 1990 Jun; 17(6):846-8. PubMed ID: 2388211
[TBL] [Abstract][Full Text] [Related]
8. [Rheumatoid arthritis, methothrexate, and pulmonary fibrosis: which evidences?].
Schaller D; Nendaz M; Gabay C
Rev Med Suisse; 2010 Mar; 6(240):547-8, 550, 552-4. PubMed ID: 20408459
[TBL] [Abstract][Full Text] [Related]
9. Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy.
Ros S; Juanola X; Condom E; Cañas C; Riera J; Guardiola J; Del Blanco J; Rebasa P; Valverde J; Roig-Escofet O
Scand J Rheumatol; 2002; 31(6):330-6. PubMed ID: 12492247
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
[TBL] [Abstract][Full Text] [Related]
11. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
Minocha A; Dean HA; Pittsley RA
Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B.
Tang KT; Hung WT; Chen YH; Lin CH; Chen DY
Sci Rep; 2016 Mar; 6():22387. PubMed ID: 26928373
[TBL] [Abstract][Full Text] [Related]
13. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.
Kremer JM; Lee RG; Tolman KG
Arthritis Rheum; 1989 Feb; 32(2):121-7. PubMed ID: 2920047
[TBL] [Abstract][Full Text] [Related]
14. [A patient with rheumatoid arthritis who developed liver cirrhosis after increased soft drinks intake].
Yamashita N; Miyagi Y; Maekawa M; Tsukamoto H
Nihon Ronen Igakkai Zasshi; 2022; 59(2):244-248. PubMed ID: 35650059
[TBL] [Abstract][Full Text] [Related]
15. Hepatic fibrosis in rheumatoid arthritis patients treated with methotrexate: application of a new semi-quantitative scoring system.
Richard S; Guerret S; Gerard F; Tebib JG; Vignon E
Rheumatology (Oxford); 2000 Jan; 39(1):50-4. PubMed ID: 10662873
[TBL] [Abstract][Full Text] [Related]
16. Liver cirrhosis due to methotrexate in a patient with rheumatoid arthritis.
ter Borg EJ; Seldenrijk CA; Timmer R
Neth J Med; 1996 Dec; 49(6):244-6. PubMed ID: 8990864
[TBL] [Abstract][Full Text] [Related]
17. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
Sante; 2001; 11(3):195-200. PubMed ID: 11641084
[TBL] [Abstract][Full Text] [Related]
18. Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study.
Dubey L; Chatterjee S; Ghosh A
Indian J Pharmacol; 2016; 48(5):591-594. PubMed ID: 27721549
[TBL] [Abstract][Full Text] [Related]
19. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis.
Walker AM; Funch D; Dreyer NA; Tolman KG; Kremer JM; Alarcón GS; Lee RG; Weinblatt ME
Arthritis Rheum; 1993 Mar; 36(3):329-35. PubMed ID: 8452577
[TBL] [Abstract][Full Text] [Related]
20. Cirrhosis in patients with rheumatoid arthritis receiving low dose methotrexate.
Chandran G; Ahern MJ; Hall PD; Geddes R; Smith MD; Hill W; Harley JH
Br J Rheumatol; 1994 Oct; 33(10):981-4. PubMed ID: 7921763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
